Bayerin Q1 raportissa mainintaa Nubeqan voittokulusta “Our launch assets Nubeqa™ and Kerendia™ continued to perform particularly well, growing 80 percent year-on-year and reaching combined sales of 680 million euros.”
11 tykkäystä